Clinical Trial Update: N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for N-acetylcysteine in acute exacerbation of chronic obstructive pulmonary disease is noted, with the phase and status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Queen Mary Hospital, Hong Kong | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: UNKNOWN